KAMADA EACH LIFE IS UNIQUE
LIVE

Serial Number

99333233

Owner

KAMADA LTD.

Attorney

Ben Natter

Filing Date

Aug 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

KAMADA EACH LIFE IS UNIQUE Trademark

Serial Number: 99333233 • Registration: 8161176

KAMADA EACH LIFE IS UNIQUE is a trademark filed by KAMADA LTD. on August 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

KAMADA LTD. (11 trademarks)

Kiryat Weizmann
Rehovot 76327 , IL

Entity Type: 16

Trademark Details

Filing Date

August 12, 2025

Registration Date

March 3, 2026

Published for Opposition

January 13, 2026

Goods & Services

Pharmaceuticals namely plasma derived and recombinant immunoglobulins for use in the treatment of infectious diseases including CMV disease, Hepatitis B, Varicella Zoster, and rabies, Hematologic conditions including Idiopathic Thrombocytopenic Purpura (ITP). Respiratory conditions including Alpha-1 Antitrypsin Deficiency, Obstetrics and Gynecology (OBGYN) conditions such as hemolytic disease of the newborn, Transplantation treatments including solid-organ transplants and hematopoietic stem-cell transplantation (HSCT); pharmaceuticals namely plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals namely coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thrombo-embolic disorders; pharmaceutical preparations for anesthesia analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for the treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for the treatment of Rabies.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 3, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 3, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 13, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 13, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 7, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 12, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 12, 2025 NWOS
NEW APPLICATION ENTERED
Aug 12, 2025 NWAP